Biophysical insights into the relationship between plasma viscosity and atherogenic risk factors among patients who underwent CABG surgery

Abstract

Plasma viscosity (PV) is an important determinant of blood flow and hemorheological behavior. Plasma plays a crucial role behaving as an interface between blood and vessel wall. Disturbed blood flow in atherosclerotic arteries, together with elevated plasma fibrinogen and endothelial dysfunction, may trigger mechanical stress on endothelial cells, from which nitric oxide (NO) is secreted. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase enzyme, is an increased marker for atherosclerosis. The present study was designed to investigate the relationship between PV and atherogenic risk factors in severe atherosclerotic patients underwent coronary artery bypass grafting surgery (CABG). Twenty-three male patients with severe atherosclerosis who underwent CABG were divided into two groups according to serum total cholesterol levels (Total-C) (Group 1(n:12): Total-C<200 mg/dL; Group 2(n:11): Total-C>200 mg/dL). PV, plasma fibrinogen, plasma NO and plasma ADMA were measured before operation (PreOp), on 1st day after operation (P1) and on 7th day after operation (P7). Group 1 had higher P1 and P7 plasma fibrinogen levels than PreOp (p<0.001) and Group 2 had higher P7 plasma fibrinogen levels than PreOp (p<0.05). PreOp PV was higher in Group 2 compared with Group 1 (p<0.05), whereas P7 PV levels decreased significantly after CABG operation in Group 2 (p<0.05). P7 PV levels were significantly higher than PV levels of PreOp and P1 in Group 1 (p<0.05). P1 PV levels of Group 2 decreased statistically significantly compared with PreOp levels (p<0.01). There was no statistically significant difference by means of plasma NO and ADMA levels among study groups. Group 2 had a less favorable serum lipid profile than Group 1. In conclusion, an unfavorable lipid profile and a higher atherogenic index before surgery, together with elevated PV levels, may reflect greater atherosclerotic burden in CABG patients. PV values decreased due to hydration and plasma fibrinogen increased just after surgery in both study groups. Higher fibrinogen levels despite hydration might be a result of high surgical stress, as an acute phase reactant. These findings suggest that the mechanical change of PV in early period after CABG might be more effective than plasma NO and ADMA.

Keywords

• Atherogenic risk factors
• coronary artery bypass grafting
• plasma viscosity
• total cholesterol
• nitric oxide

References

1. Araujo, G., Valencia, L. M., Martin-Ozimek, A., Soto, Y., & Proctor, S. D. (2025). Atherosclerosis: From lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins. Frontiers in Immunology, 16, 1485801.
2. Caimi, G., Urso, C., Brucculeri, S., Amato, C., Carlisi, M., & Lo Presti, R. (2021). An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different degrees of insulin resistance. Clinical Hemorheology and Microcirculation, 78(4), 417-428.
3. Calapkulu, Y., Erdogan, M., Aslan, A. N., Akar, N., Bulguroglu, S., Kardesler, D., & Erdol, M. A. (2025). Evaluation of whole blood viscosity to predict stent restenosis in patients with coronary artery disease. Anatolian Journal of Cardiology, 29(9), 503-511.
4. Carlisi, M., Lo Presti, R., Mancuso, S., Siragusa, S., & Caimi, G. (2023). Calculated whole blood viscosity and albumin/fibrinogen ratio in patients with a new diagnosis of multiple myeloma: Relationships with some prognostic predictors. Biomedicines, 11(3), 964.
5. Casino, P. R., Kilcoyne, C. M., Quyyumi, A. A., Hoeg, J. M., & Panza, J. A. (1993). The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation, 88(6), 2541-2547.
6. Chen, L., Qu, H., Liu, B., Chen, B. C., Yang, Z., Shi, D. Z., & Zhang, Y. (2024). Low or oscillatory shear stress and endothelial permeability in atherosclerosis. Frontiers in Physiology, 15, 1432719.
7. Cheng, C. K., Wang, N., Wang, L., & Huang, Y. (2025). Biophysical and biochemical roles of shear stress on endothelium: A revisit and new insights. Circulation Research, 136(7), 752-772.
8. Ercan, M., Koksal, C., Konukoglu, D., Bozkurt, A. K., & Onen, S. (2003). Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease. Clinical Hemorheology and Microcirculation, 29(1), 3-9.

9. Ercan, M., Konukoglu, D., & Erdem Yesim, T. (2006). Association of plasma viscosity with cardiovascular risk factors in obesity: An old marker, a new insight. Clinical Hemorheology and Microcirculation, 35(4), 441-446.
10. Feron, O., Dessy, C., Moniotte, S., Desager, J. P., & Balligand, J. L. (1999). Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. Journal of Clinical Investigation, 103(6), 897-905.
11. Förstermann, U., Xia, N., & Li, H. (2017). Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circulation Research, 120(4), 713-735.
12. Goudhaman, L., Raja Jagadeesan, A., Sundaramoorthi, S., Thotla, S., & Krishna Mohan, S. (2021). Association of serum asymmetric dimethylarginine with the severity of coronary artery disease: A pilot study. Reports of Biochemistry and Molecular Biology, 10(2), 302-306.
13. Hsu, P. S., Chen, J. L., Sung, S. Y., Tsai, Y. T., Lin, C. Y., Wu, Y. F., & Tsai, C. S. (2023). Inflammatory biomarkers and blood physical property transformations following on-pump coronary artery bypass graft surgery. Journal of Personalized Medicine, 13(10), 1434.
14. Jang, Y., Lee, J. H., Cho, E. Y., Chung, N. S., Topham, D., & Balderston, B. (2001). Differences in body fat distribution and antioxidant status in Korean men with cardiovascular disease with or without diabetes. The American Journal of Clinical Nutrition, 73(1), 68-74.
15. Jung, F., Pindur, G., & Kiesewetter, H. (1992). Plasma viscosity dependence on proteins and lipoproteins: Results of the Aachen study. Clinical Hemorheology and Microcirculation, 12(4), 557-571.
16. Kesmarky, G., Toth, K., Habon, L., Vajda, G., & Juricskay, I. (2025). Hemorheological parameters in coronary artery disease. Clinical Hemorheology and Microcirculation, 18(4), 245-251.
17. Koenig, W., Sund, M., Filipak, B., Döring, A., Löwel, H., & Ernst, E. (1998). Plasma viscosity and the risk of coronary heart disease: Results from the Monica-Augsburg cohort study. Arteriosclerosis, Thrombosis, and Vascular Biology, 18(5), 768-772.
18. Konstantinova, E., Tolstaya, T., Prinshchep, S., Milutin, A., Mironova, E., & Ivanova, L. (2004). Plasma lipid levels, blood rheology, platelet aggregation, microcirculation state and oxygen transfer to tissues in young and middle-aged healthy people. Clinical Hemorheology and Microcirculation, 30(3-4), 443-448.
19. Lowe, G. D. O., Harris, K., Koenig, W., Ben-Shlomo, Y., Thorand, B., Peters, A., Meisinger, C., Imhof, A., Tunstall-Pedoe, H., Peters, S. A. E., & Woodward, M. (2024). Plasma viscosity, immunoglobulins and risk of cardiovascular disease and mortality: New data and meta-analyses. Journal of Clinical Pathology, 77(6), 394-401.
20. Lu, L., Xie, J., Xiang, Y., Zheng, Y., Wu, T., Lv, D., & Xu, T. (2025). The relationship between hemorheology and carotid atherosclerosis. The Journal of Practical Medicine, 41(19), 3041-3045.
21. Marcinkowska-Gapińska, A., & Siemieniak, I. (2025). The effect of statin therapy on hemorheological parameters of patients with clinically silent ischemic foci of the brain. International Journal of Molecular Sciences, 26(15), 7039.
22. McNichols, B., Spratt, J. R., George, J., Rizzi, S., Manning, E. W., & Park, K. (2021). Coronary artery bypass: Review of surgical techniques and impact on long-term revascularization outcomes. Cardiology and Therapy, 10(1), 89-109.
23. Mensah, G. A., Arnold, N., Prabhu, S. D., Ridker, P. M., & Welty, F. K. (2025). Inflammation and cardiovascular disease: 2025 ACC scientific statement: A report of the American College of Cardiology. Journal of the American College of Cardiology, 25, 07555-2.
24. Mowat, B. F., Skinner, E. R., Wilson, H. M., Leng, G. C., Fowkes, F. G., & Horrobin, D. (1997). Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease. Atherosclerosis, 131(2), 161-166.
25. Mueller, R. (1981). Hemorheology and peripheral vascular disease: A new therapeutic approach. Journal of Medicine, 12(4), 209-212.
26. Muravyov, A. V., Yakusevic, V. V., Surovaya, L., & Petrockenko, A. (2004). The effect of simvastatin therapy on hemorheological profile in coronary heart disease (CHD) patients. Clinical Hemorheology and Microcirculation, 31(4), 251-256.
27. Neubauer-Geryk, J., Wielicka, M., Hoffmann, M., Myśliwiec, M., & Bieniaszewski, L. (2024). The impact of disease duration on microcirculatory dysfunction in young patients with uncomplicated type 1 diabetes. Biomedicines, 12(5), 1020.
28. Noh, S. M. (2025). Clinical significance of blood viscosity in patients with acute ischemic stroke. Scientific Reports, 15, 22424.
29. Peters, S. A., Woodward, M., Rumley, A., Tunstall-Pedoe, H. D., & Lowe, G. D. (2017). Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study. European Journal of Preventive Cardiology, 24(2), 161-167.
30. Rodrigues, A., Sousa, A. C., Gouveia, J. A., Nunes, P., Gomes, S., Almada, S., Sa, D., Abreu, G., Rodrigues, M., Freitas, S., Henriques, E., Borges, S., Oliveira, M. J., Mendonca, M. I., & Palma Dos Reis, R. (2025). The importance of fibrinogen as a cardiovascular risk factor. European Heart Journal, 46(Supplement_1), ehaf784.3548.
31. Sipahioglu, N., Karis, D., Uzun, H., Sipahioglu, F., Ercan, S., & Ercan, A. M. (2015). The effect of ezetimibe on plasma viscosity, fibrinogen and lipid profile. Medical Science and Discovery, 2(6), 339-344.
32. Stezycka, J., Kolasa, A., Pomin, K., Stoklosa, K., Potrawiak, S., Bergmann, K., Kaczmrek, F., & Marcinkowska-Gapinska, A. (2026). Cardiac surgery and hemorheological parameters: A literature review. Quality in Sport, 43, 61409.
33. Tanczos, B., Somogyi, V., Bombicz, M., Juhasz, B., Nemeth, N., & Deak, A. (2021). Changes of hematological and hemorheological parameters in rabbits with hypercholesterolemia. Metabolites, 11(4), 249.
34. Toh, J. M., Yong, J., Abrams, S. T., Wang, L., Schofield, J., Lane, S., La Corte, A. C., Wang, S. S., Ariëns, R. A. S., Philippou, H., Xie, J., Yu, W., Wang, G., & Toh, C. H. (2024). Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes. Journal of Thrombosis and Haemostasis, 22(8), 2247-2260.
35. Valeanu, L., Ginghina, C., & Bubenek-Turconi, S. (2022). Blood rheology alterations in patients with cardiovascular diseases. Romanian Journal of Anaesthesia and Intensive Care, 28(2), 41-46.
36. Velcheva, I., Antonova, N., & Kmetski, T. (2025). Significance of whole blood viscosity in acute ischemic stroke. Life, 15(12), 1869. Von Clauss, A. (1957). Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica, 17(4), 237-246. Wang, G., Yang, F., Zhou, W., Xiao, N., Luo, M., & Tang, Z. (2023). The initiation of oxidative stress and therapeutic strategies in wound healing. Biomedicine & Pharmacotherapy, 157, 114004.